GlycanAge

GlycanAge is a biotechnology company specializing in biological age testing through advanced glycomic analysis. The core product is an at-home test kit that measures biological age by analyzing glycosylation patterns on Immunoglobulin G (IgG) proteins in a small blood sample. These glycan patterns are sensitive indicators of chronic inflammation and are influenced by lifestyle, providing a more dynamic and actionable measure of aging than genetic or epigenetic clocks. The test is based on over 30 years of scientific research and more than 200,000 samples, with findings regularly published in leading medical journals.

The process is straightforward: users collect a few drops of blood using the provided kit, send it to the lab, and receive a detailed report within three weeks. Each test includes a complimentary consultation with a specialist, who interprets the results and offers personalized lifestyle recommendations to optimize health and potentially reduce biological age. GlycanAge’s approach is unique in its responsiveness to lifestyle changes, making it a valuable tool for individuals seeking to track the effectiveness of interventions such as diet, exercise, or menopause management.

GlycanAge’s technology is underpinned by a robust scientific foundation and is used by both health enthusiasts and researchers. The company is also expanding its reach into disease diagnostics, leveraging glycan biomarkers for early detection and precision medicine. Its recent funding and collaborations highlight its role as a pioneer in the field of preventative healthcare and longevity science.

Keywords: biological age, glycans, glycomic analysis, Immunoglobulin G, chronic inflammation, lifestyle, personalized health, preventative healthcare, longevity, diagnostics, biomarkers, at-home test, menopause management, biotechnology.